Article Information
History
- April 17, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 17, 2020 - 03:30).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Bin Wang#,1,
- Li Wang#,1,
- Xianggen Kong1,
- Jin Geng1,
- Di Xiao1,
- Chunhong Ma2,
- Xue-Mei Jiang1,* and
- Pei-Hui Wang2,*
- 1Jinan Infectious Diseases Hospital of Shandong University, Jinan, Shandong 250021, China
- 2Advanced Medical Research Institute, Shandong University, Jinan, Shandong 250012, China
- ↵*To whom correspondence should be addressed: Xue-Mei Jiang, shdjxm{at}163.com; Pei-Hui Wang, wphlab{at}163.com
↵# These authors contributed equally to this work
Posted April 17, 2020.
Long-term Coexistence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) with Antibody Response in Coronavirus Disease 2019 (COVID-19) Patients
